Drug Stocks Favored by Funds

Description:

According to Robert Holmes, "Drug stocks such as Johnson & Johnson (JNJ) and Gilead Sciences (GILD) have been beaten up in the year since the health-care reform bill was passed. That may soon change, as fund managers are pouncing on shares of undervalued companies." Here are the health-care equity picks of two fund managers and an analyst. Read more here.

>>Also: 10 Buy-Rated Stocks Under $5

>>Also: 4 Small Stocks With Buyout Rumors

Most Viewed Portfolios

View All

Articles

4 Huge Stocks to Trade (or Not)

08.18.14 | 12:00 PM

BALTIMORE (Stockpickr) -- Put down the 10-K filings and the stock screeners. It's time to take a break from the traditional methods of generating ...

5 Rocket Stocks to Buy for Gains This Week

08.18.14 | 11:45 AM

BALTIMORE (Stockpickr) -- The big bounce in the S&P 500 followed through last week, ending the big index 1.2% higher on Friday than it started Mond...

More Articles
blog comments powered by Disqus
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter